Track Response Genetics's receivables ($6.1M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Response Genetics (RGDXQ) currently reports a receivables of $6.1M as of March 2015. That compares with $5.5M in the prior-year period — up 9.6% year over year. Use the charts on this page to explore Response Genetics's receivables history and peer comparisons.
Response Genetics's receivables increased from $5.5M to $6.1M — a 9.6% year-over-year increase (period ending March 2015). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Response Genetics reported $6.1M in receivables as of March 2015. That compares with $5.5M in the prior-year period — up 9.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $6.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Response Genetics, and consider following RGDXQ for alerts when major investors trade the stock.